US Genetic Testing Market Size, Share, Trends & Forecast
The US Genetic Testing Market was valued at USD 3.7 billion in 2024 and is projected to reach USD 23.8 billion by 2035, registering a CAGR of 18.44% from 2025 to 2035. Increasing consumer awareness, technological advances, regulatory developments, and rising demand for personalized medicine are contributing to market expansion.
The market includes single-gene tests, panel tests, whole exome sequencing, whole genome sequencing, and non-invasive prenatal testing. Whole exome sequencing represents the largest testing category in the report, while non-invasive prenatal testing is identified as a rapidly growing segment. Advances in genomic technologies are expanding the applications of genetic analysis across healthcare.
Prenatal testing holds the largest application share, while newborn screening is experiencing rapid growth. Carrier testing, diagnostic testing, and predictive testing also contribute to demand as healthcare providers and consumers place greater emphasis on identifying genetic risks and supporting preventive healthcare.
Clinical laboratories represent the largest end-user segment, supported by established infrastructure and specialized testing capabilities. Hospitals are also expanding their genetic testing services as genomic information becomes increasingly integrated into routine clinical care and personalized treatment planning.
Explore additional reports to understand evolving market landscapes: